Impact of Hepatitis B Exposure on Sustained Virological Response Rates of Highly Viremic Chronic Hepatitis C Patients

Table 1

Epidemiological, serological, virological, and histological baseline data of the study population. IVDU: intravenous drug users; HCV: hepatitis C virus; Anti-HBc: antibody against Hepatitis B core antigen.

Gender (male/female)	124/61
Greeks (%)	82.7
Non-Greeks (%)	17.3
IVDU (%)	70.2
HCV genotype-1 (%)	47.6
HCV genotype-2 (%)	3.6
HCV genotype-3 (%)	36.3
HCV genotype-4 (%)	12.5
Cirrhosis (%)	14.4
Anti-HBc-negative (%)	70
Anti-HBc-positive (%)	30
■ Anti-HBs positive (%)	■   84.3
■ HBV-DNA negative (%)	■ 98.03